NEWS: USPTO Issues First Director Review Decisions
By Matt Johnson - On July 6th and 7th, the USPTO made good on its promise to not wait for a confirmed director to begin Arthrex Director reviews, issuing its first denials of review requests. The full press release is below: USPTO issues first Director review...
District Court Highlights Prior PTAB Invalidation
By Zach Sharb and Josh Nightingale - On May 26, 2021, the United States District Court for the Western District of Washington denied both defendant Valve Corporation’s (“Valve”) motion for judgment as a matter of law or a new trial, and plaintiff Ironburg Inventions...
Fed. Cir.: Don’t Expect PTAB to Do Your Work For You
By Albert Liou - The Federal Circuit’s recent decision in Microsoft Corporation v. FG SRC, LLC, No. 2020-1928 (Fed. Cir. June 17, 2021), is a stark reminder that an IPR petitioner must always set forth its grounds in its petition with particularity. In the decision,...
A Cautionary Tale: Paying IPR Filing Fees Via Wire Transfer
By Alison Ibendahl and Joseph Beauchamp - A June 25, 2021 decision by the PTAB has clarified that when paying the filing fee via wire transfer, the inter partes review (“IPR”) petition filing date is based upon when the funds are made available to the USPTO. Toshiba...
USPTO updates Arthrex Q&As
By Matt Johnson - On July 20th, the PTAB provided additional clarifications regarding its views on Arthrex and how its interim procedures for requesting Director review will work for cases receiving Final Written Decisions on a going forward basis (i.e., not cases...